Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first quarter of 2027 RENO, Nev., Oct. 15, 2026 (GLOBE NEWSWIRE) — Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage medical device and regenerative…

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at financialpost.com →

More in Finance & Markets

More from Thursday 15 October →